2seventy bio to Participate in CG Horizons in Oncology Virtual Conference
2seventy bio (Nasdaq: TSVT) will present at the CG Horizons in Oncology Virtual Conference on April 14, 2022, at 1:30 PM ET. The focus will be on new approaches to attacking AML. Live webcasts of the presentations will be accessible in the Investors and Media section of the company's website, with replays available for 30 days afterward. 2seventy bio aims to revolutionize cancer therapies through innovative cell treatments, emphasizing speed and efficacy in research and development.
- None.
- None.
Live webcasts of presentations will be available via the Investors and Media section of 2seventy bio’s website at https://ir.2seventybio.com/. A replay of each presentation will be archived on 2seventy bio’s site for 30 days following the event.
About 2seventy bio
Our name, 2seventy bio, reflects why we do what we do - TIME. Cancer rips time away, and our goal is to work at the maximum speed of translating human thought into action – 270 miles per hour – to give the people we serve more time. We are building the leading immuno-oncology cell therapy company, focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape With a deep understanding of the human body’s immune response to tumor cells and how to translate cell therapies into practice, we’re applying this knowledge to deliver next generation cellular therapies that focus on a broad range of hematologic malignancies, including the first FDA-approved CAR T cell therapy for multiple myeloma, as well as solid tumors. Our research and development is focused on delivering therapies that are designed with the goal to “think” smarter and faster than the disease. Importantly, we remain focused on accomplishing these goals by staying genuine and authentic to our “why” and keeping our people and culture top of mind every day.
For more information, visit www.2seventybio.com.
Follow 2seventy bio on social media: Twitter and LinkedIn.
2seventy bio is a trademark of
View source version on businesswire.com: https://www.businesswire.com/news/home/20220407005067/en/
Investors:
elizabeth.pingpank@2seventybio.com
Media:
victoria.wagner@2seventybio.com
morgan.adams@2seventybio.com
Source:
FAQ
When is 2seventy bio's presentation at the CG Horizons in Oncology Virtual Conference?
What is the focus of 2seventy bio's presentation at the conference?
How can I watch 2seventy bio's conference presentation?
Will 2seventy bio's presentation be available after the event?
What is the stock symbol for 2seventy bio?
